Old Web
English
Sign In
Acemap
>
authorDetail
>
Pascal Girard
Pascal Girard
Merck & Co.
Pharmacokinetics
Medicine
Pharmacodynamics
Tolerability
Internal medicine
3
Papers
49
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Translational Pharmacokinetic-pharmacodynamic Modelling of Preclinical and Clinical Data of the Oral MET Inhibitor Tepotinib to Determine the Recommended Phase II Dose.
2021
Wenyuan Xiong
Manja Friese-Hamim
Andreas Johne
Christopher Stroh
Manfred B. Klevesath
Gerald Steven Falchook
David S. Hong
Pascal Girard
Samer El Bawab
Show All
Source
Cite
Save
Citations (0)
First-in-Man Phase I Trial of the Selective MET Inhibitor Tepotinib in Patients with Advanced Solid Tumors.
2019
Clinical Cancer Research
Gerald Steven Falchook
Razelle Kurzrock
Hesham M. Amin
Wenyuan Xiong
Siqing Fu
Sarina Anne Piha-Paul
Filip Janku
Ghazaleh Eskandari
Daniel V.T. Catenacci
Manfred B. Klevesath
R. Bruns
Uz Stammberger
Andreas Johne
Friedhelm Bladt
Manja Friese-Hamim
Pascal Girard
Samer El Bawab
David S. Hong
Show All
Source
Cite
Save
Citations (25)
Time‐Varying Clearance and Impact of Disease State on the Pharmacokinetics of Avelumab in Merkel Cell Carcinoma and Urothelial Carcinoma
2019
Justin Wilkins
Brigitte Brockhaus
Haiqing Dai
Yulia Vugmeyster
Joleen T. White
Satjit S. Brar
Carlo L. Bello
Berend Neuteboom
Janet R. Wade
Pascal Girard
Akash Khandelwal
Show All
Source
Cite
Save
Citations (24)
1